Gout Self-Management App: eHealth Tool for People with Gout
- : Australia
This GP Research Activity aims to improve the effectiveness of management of patients with gout, who often are not adherent to their serum urate-lowering therapy (ULT), and whose gout is not controlled.
The trial component of the activity will compare the effectiveness of two mobile apps, designed to assist people with gout in self-managing their gout. Participating GPs are requested to identify, screen, and recruit at least 3 patients, who have had at least one attack of gout in the past 12 months, are receiving or eligible to receive ULT to prevent attacks and have access to a smartphone or tablet with access to the internet. GPs will review the patients at least 3 times within 1 year after gaining consent from the patients (0, 6 and 12 months), and monitor their serum uric acid and creatinine levels as required.
The activity also involves eLearning modules on cluster randomised controlled trials at the start and the management of gout at the completion of trial participation.
Gout prevalence is increasing despite effective therapies to lower serum urate concentrations to 0.36 mmol/L or less, which, if sustained, significantly reduces acute attacks of gout. Adherence to urate lowering therapy (ULT) is poor, with rates of less than 50% one year after initiation of ULT. Innovative self-management tools are needed to address this issue. These mobile apps are designed to be integrated into primary care, and if found to be effective, have the potential to become a patient-centred self-management tool to be used in routine chronic care for gout patients.
Results of the trial will be critical in providing robust evidence to inform the appropriate use of electronic self-management tools in patients with gout. The study will inform aspects of the use of apps in general practice, that may be useful in other health conditions.